**Cogent Biosciences Signs New Headquarters Lease in Waltham, MA**
Cogent Biosciences, Inc. has signed a 31,518-square-foot lease at 180 CityPoint, a Class A office and life sciences building in Waltham, Massachusetts. The property is owned and operated by BXP. This new lease marks a relocation of Cogent’s corporate headquarters from 275 Wyman Street as the company prepares to commercialize its first product.
The leasing transaction was facilitated by Cushman & Wakefield, with Michael O’Leary, Kevin McNamara, Thomas Ashe, and Ross Gaudet representing Cogent Biosciences. BXP was self-represented by Pat Mulvihill, Senior Vice President of Leasing, and Casey Torto, Leasing Manager for the company’s Boston region.
“This headquarters lease underscores the shift of innovative biotech companies coming to Waltham, which offers the high-quality space and accessibility that companies primarily once looked for in Cambridge,” said Kevin McNamara of Cushman & Wakefield. “Cogent will benefit from a state-of-the-art environment that supports the firm’s culture, recruitment, and long-term success.”
Cogent’s move comes on the heels of another recent lease at 180 CityPoint. Amplitude Vascular Systems also relocated to the building from Boston’s Seaport District, occupying 38,000 square feet.
**Upcoming Industry Event**
Industry leaders from CommonSpirit, Meridian, Adventist Health, and Anchor Health will be sharing insights shaping the future of healthcare real estate at the upcoming Connect Healthcare Real Estate event, taking place October 14–15 in Irvine, California.
